Stephanie Essiaw Tagoe, OT/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 10021 Howell Dr, Upper Marlboro, MD 20774 Phone: 703-398-7865 |
Firststep Rehab, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1717 Largo Rd, Upper Marlboro, MD 20774 Phone: 240-506-9345 |
Terri Redd Ellerbe, MOT, LOTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15208 Richard Bowie Ln, Upper Marlboro, MD 20774 Phone: 202-258-5455 |
News Archive
Physician-scientists from Children's Hospital of Philadelphia presented updated efficacy and safety data on Kymriah-the first-ever U.S. Food and Drug Administration approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers at the 60th American Society of Hematology annual meeting, as well as first-of-its-kind research on overcoming CAR T-cell resistance.
Data Advantage, LLC announced today the Top 100 Hospital: Best in Value Hospitals™ list from the 2009-2010 Hospital Value Index™, the first and only national study on U.S. hospitals and the value of care they provide.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has expanded its plans for its United States Food and Drug Administration (FDA) Expanded Access Treatment IND Program for its flagship product, Generex Oral-lyn™, to include licensed and qualified Nurse Practitioners in the United States.
QRxPharma Limited announced today positive results of its Phase 2 comparative proof-of-concept study to evaluate the efficacy and safety of its IV (intravenous) formulation of morphine plus oxycodone versus IV morphine alone for the treatment of moderate to severe post-operative pain in patients following hip replacement surgery. The main findings demonstrated that QRxPharma's formulation of MoxDuo IV resulted in fewer side effects and offered better pain relief than morphine alone.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.
› Verified 7 days ago